Clinical Trial Update: A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of A-60444 for Respiratory Syncytial Virus infection in adults following hematopoietic stem cell transplantat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• A-60444

Snippet

Sponsor: Arrow Therapeutics | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED